Graduated in Biological Sciences from Pontifícia Universidade Católica de Campinas (2003). Developed a project of Scientific Initiation (2003 / FAPESP). He obtained a Master's Degree in Pharmacology from the State University of Campinas (2006 / CNPq). He holds a PhD in the Postgraduate Science course (Immunology Program) of the Biomedical Sciences Institute of the University of São Paulo (2010 / FAPESP). Trainee at the Laboratory of Human Genetics of Professor Jean Laurent Casanova, Paris, France (2011 to 2013 / FAPESP). He completed his Post-Doctorate at the Biomedical Sciences Institute of the University of São Paulo at the Laboratory of Human Immunology (2014/2015). Acquired extensive experience in the areas of Human Genetics, Molecular Biology, Immunology and Pharmacology, working mainly in the following subjects: Primary Immunodeficiencies (Errors of Innate Immunity); Investigation of mutations and polymorphisms by means of new generation sequencing (NGS - Genome / Exoma); Study of intracellular mechanisms and interactions with drugs. He is currently a founding member of IMMUNOGENIC, a startup born within the Institute of Biomedical Sciences (ICB) and incubated at the Center for Innovation, Entrepreneurship and Technology (CIETEC / USP), dedicated to the research and development of diagnostic tests for Errors of Innate Immunity and Allergies (address to access this CV: http://lattes.cnpq.br/585290274484739) (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Primary immunodeficiencies (PIDs) are a group of heterogeneous diseases that manifest early in life in the form of recurrent severe infections, autoimmunity, autoinflammation, severe allergy, or susceptibility to cancer. The purpose of neonatal screening is to identify asymptomatic newborns with potentially serious or life-threatening conditions that are treatable, resulting in a signific…
Primary immunodeficiencies (PIDs) are a group of diseases with heterogeneous expression, which usually manifest from the first days of life to seven years of age. The objective of neonatal screening is to identify asymptomatic newborns with potentially serious or fatal diseases with the possibility of treatment, resulting in a significant reduction of morbidity and mortality. The Kappa / …
In the scope of our business activities, we aim to research and development of diagnostic tests aimed at diseases of the immune system: allergies, congenital immunodeficiency and autoimmune diseases. In this project, we propose the improvement of diagnostic tests for the neonatal period, allowing for early detection of congenital immunodeficiency, focusing on severe immunodeficiency (SCID…
(Only some records are available in English at this moment)
Tuberculosis is an infectious disease caused by mycobacterium tuberculosis complex. The main pathogen is Mycobacterium tuberculosis. Approximately 8 million new cases and 2 million deaths are reported each year. Through the study of the susceptibility Mendelian diseases caused by mycobacteria (MSMD), mutations were identified in six genes related to the operation axis interleukin 12 (IL-1…
| 3 / 3 | Completed research grants |
| 8 / 6 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 12 / 10 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID
Google Scholar Citations